Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects.

Author: KansraVikram, LuSharon, PowersDan, WangJing, WangXiaodong, ZhangZhi-Yi

Paper Details 
Original Abstract of the Article :
Rolapitant is a neurokinin-1 receptor antagonist indicated in combination with other antiemetic agents in adults for the prevention of delayed chemotherapy-induced nausea and vomiting. We evaluated the effects of rolapitant oral on the pharmacokinetics of probe substrates for cytochrome P450 (CYP) 2...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373243/

データ提供:米国国立医学図書館(NLM)

Rolapitant: A Potential Drug-Drug Interaction?

Drug-drug interactions are a common concern in medicine, as the combination of different medications can sometimes lead to unexpected and potentially harmful effects. This research investigates the potential for rolapitant, a drug used to prevent chemotherapy-induced nausea and vomiting, to interact with other medications metabolized by certain enzymes in the liver. The study specifically examined the effects of rolapitant on the pharmacokinetics of several probe substrates for different cytochrome P450 (CYP) enzymes. The researchers aimed to determine whether rolapitant affects the metabolism of other medications, potentially altering their effectiveness or increasing the risk of side effects.

Understanding Drug Interactions: A Crucial Aspect of Patient Safety

The findings of this study provide valuable insights into the potential for drug-drug interactions involving rolapitant. By carefully analyzing the pharmacokinetic interactions between rolapitant and other medications, clinicians can make informed decisions about drug combinations and optimize patient safety. The researchers' meticulous investigation highlights the importance of considering potential drug interactions, particularly when prescribing medications for patients receiving chemotherapy, as these individuals may be more susceptible to adverse effects.

Collaboration for Optimal Care: Sharing Information to Ensure Safety

This study emphasizes the importance of open communication and collaboration between healthcare providers, pharmacists, and patients when prescribing medications. By sharing information about potential drug interactions and patient medication histories, healthcare professionals can work together to minimize the risk of adverse events and ensure the safe and effective use of medications.

Dr. Camel's Conclusion

This research reminds us that the world of medicine is a complex and interconnected one. Just like the intricate network of dunes in a desert, the different medications we take can interact with each other in unexpected ways. This study encourages us to approach medication management with caution and meticulousness, ensuring the safety and well-being of our patients.

Date :
  1. Date Completed 2019-03-25
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

30084103

DOI: Digital Object Identifier

PMC6373243

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.